2.5 tirzepatide Instructions Tirzepatide Dosing for Weight Loss

The complete supplement protocol for someone on keto plus GLP-1 should include: Electrolytes (sodium, potassium, magnesium) throughout the day Creatine monohydrate: 3 to 5 grams daily Omega-3 fish oil: 2 to 3 grams EPA/DHA combined Vitamin D3: 2,000 to 5,000 IU daily (test levels and adjust) B12: 1,000 mcg methylcobalamin daily Probiotic: multi-strain, 10+ billion CFU Fiber supplement: psyllium husk, 5 to 10 grams daily as needed for bowel regularity Collagen peptides: 10 to 20 grams daily for connective tissue support (also contributes to protein intake) Tirzepatide-specific supplement considerations mirror the general protocol but may require higher electrolyte doses during the initial adaptation period due to the more aggressive appetite suppression and potential for greater fluid shifts

C.HooperG

When both medicines produce similar sensations, the combined effect can make daily activities harder

Side-by-Side Comparison Feature Structure Melanotan 2 Cyclic 7-amino acid peptide Afamelanotide (MT-I) Linear 13-amino acid peptide PT-141 (Bremelanotide) Cyclic 7-amino acid derivative Feature Receptor focus Melanotan 2 MC1R + MC3R + MC4R + MC5R (non-selective) Afamelanotide (MT-I) MC1R-preferring PT-141 (Bremelanotide) MC3R/MC4R-preferring Feature Plasma half-life Melanotan 2 ~1-2 hours Afamelanotide (MT-I) ~0.8-1.7 hours PT-141 (Bremelanotide) ~2.7 hours Feature Main effect Melanotan 2 Tanning + sexual + appetite changes Afamelanotide (MT-I) Tanning and photoprotection PT-141 (Bremelanotide) Sexual arousal and desire Feature Tanning strength Melanotan 2 Strong Afamelanotide (MT-I) Strong PT-141 (Bremelanotide) Minimal Feature Sexual effect Melanotan 2 Strong in ED studies Afamelanotide (MT-I) Not primary PT-141 (Bremelanotide) Primary use case Feature Dosing Melanotan 2 Daily loading, then 1-2x weekly Afamelanotide (MT-I) Subcutaneous implant PT-141 (Bremelanotide) On-demand, max 1 per 24 hours Feature FDA status Melanotan 2 Not approved Afamelanotide (MT-I) Approved (Scenesse) for EPP PT-141 (Bremelanotide) Approved (Vyleesi) for low female sexual desire Feature Nausea burden Melanotan 2 High and dose-limiting Afamelanotide (MT-I) Lower in selective use PT-141 (Bremelanotide) Common, listed on label These three compounds share melanocortin ancestry, but they are not interchangeable

Rossi MA, Stuber GD (2018) Overlapping brain circuits for homeostatic and hedonic feeding